Page last updated: 2024-08-18

pyrazolanthrone and Cancer-Associated Pain

pyrazolanthrone has been researched along with Cancer-Associated Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, L; Cai, GH; Guo, CH; Ma, W; Wang, X; Wu, HH; Wu, SX; Yang, J	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Cancer-Associated Pain

Article	Year
The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain. International journal of molecular medicine, 2016, Volume: 38, Issue:5 Topics: Analgesics; Animals; Anthracenes; Astrocytes; Bone Neoplasms; Cancer Pain; Chemokine CCL2; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Female; Hyperalgesia; Inflammation Mediators; Injections, Spinal; JNK Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Spinal Cord; Up-Regulation	2016

Article

Year

The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.

International journal of molecular medicine, 2016, Volume: 38, Issue:5

Topics: Analgesics; Animals; Anthracenes; Astrocytes; Bone Neoplasms; Cancer Pain; Chemokine CCL2; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Female; Hyperalgesia; Inflammation Mediators; Injections, Spinal; JNK Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Spinal Cord; Up-Regulation

2016